AVEO Pharmaceuticals, Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ae3733ba-ea8f-435c-95a2-de076147ae8d/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $42.3M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-006093 |
| FY 2020 | $6.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013607 |
| FY 2019 | $28.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011145 |
| FY 2018 | $5.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007804 |
| FY 2017 | $7.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007804 |
| FY 2016 | $2.5M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007804 |
| FY 2015 | $19.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014772 |
| FY 2014 | $18.1M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-079651 |
| FY 2013 | $1.3M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-097636 |
| FY 2012 | $19.3M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-101343 |
| FY 2011 | $164.8M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-141748 |
| FY 2010 | $44.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-141748 |
| FY 2009 | $20.7M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-141748 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AVEO Pharmaceuticals, Inc. — all facts · Net Income · Operating Income